Trial Profile
The Impact of Alna, Ocas on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia; Nocturia
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 24 Sep 2014 New trial record